CCMI
JAZZ icon

Creative Capital Management Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Creative Capital Management Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.89K Buy
+12
New +$2.63K ﹤0.01% 646

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Creative Capital Management Investments's JAZZ Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 12 shares worth $2.89K. The stake represents ﹤0.01% of the portfolio and ranks #646 among its holdings.

130 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Creative Capital Management Investments held 12 shares of Jazz Pharmaceuticals worth $2.89K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Creative Capital Management Investments position in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #646 holding.
  • 130 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.